Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

410 trials with published results (19%)

Research Maturity

1376 completed trials (65% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.5%

75 terminated out of 2121 trials

Success Rate

94.8%

+8.2% vs benchmark

Late-Stage Pipeline

14%

287 trials in Phase 3/4

Results Transparency

30%

410 of 1376 completed with results

Key Signals

410 with results95% success75 terminated

Data Visualizations

Phase Distribution

1,685Total
Not Applicable (1009)
Early P 1 (11)
P 1 (194)
P 2 (184)
P 3 (94)
P 4 (193)

Trial Status

Completed1,376
Recruiting202
Unknown199
Not Yet Recruiting100
Active Not Recruiting93
Terminated75

Trial Success Rate

94.8%

Benchmark: 86.6%

Based on 1376 completed trials

Clinical Trials (2121)

Showing 20 of 20 trials
NCT07637669Not Yet RecruitingPrimary

Olfactory Function and Model-Based Behavior in People Living With HIV and SUD

NCT07226492Not ApplicableActive Not RecruitingPrimary

Cash Transfers to Pregnant Women With HIV

NCT00001471CompletedPrimary

Tissue Biopsy and Imaging Studies in HIV-Infected Patients

NCT06162897Not ApplicableRecruitingPrimary

Case Management Dyad

NCT02108028CompletedPrimary

Study of Voicing My CHOiCES as a Tool for Advanced Care Planning in Young Adults With Cancer

NCT05419024Phase 2RecruitingPrimary

Imaging and Biopsy of People With HIV-1 Undergoing Analytic Treatment Interruption

NCT02500849Phase 1Active Not RecruitingPrimary

Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

NCT01125228CompletedPrimary

Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV

NCT02154035RecruitingPrimary

Quantitative Measurement and Correlates of the Latent HIV Reservoir in Virally Suppressed Ugandans

NCT05505942Not ApplicableCompletedPrimary

Physical Activity for PLWH and Unhealthy Drinking

NCT06908083Phase 1Enrolling By InvitationPrimary

Immunologic and Virologic Parameters During Analytical Treatment Interruption Following Combination bNAb Therapy During Suppressive ART

NCT07851077Not ApplicableNot Yet RecruitingPrimary

Social Contact-Based Brief Video Interventions To Reduce Stigma and ImproVe Engagement in HIV Prevention and Care and Mental Health Care for Youth Living With and Vulnerable to HIV

NCT06953024Not ApplicableTerminatedPrimary

Validation of Self Testing Using the INSTI Multiplex HIV1/2 Syphilis Antibody Test

NCT06894199RecruitingPrimary

Work2Prevent Plus: Structural Intervention to Promote HIV Care in Black Sexual Minority Men

NCT07089849Not ApplicableNot Yet RecruitingPrimary

HIV Testing in Community Health Center Dental Clinics

NCT07850609Phase 2Not Yet RecruitingPrimary

A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)

NCT07227779Phase 2Recruiting

B-PaLMZ for TB Meningitis

NCT03768986Not ApplicableCompletedPrimary

A Reinforcement Intervention for Increasing HIV Testing Among At-Risk Women

NCT07432555Not ApplicableNot Yet Recruiting

Testing a Mobile Health Application to Improve HIV Prevention and Substance Use Treatment Among Women Involved in the Carceral System

NCT07199634Not ApplicableNot Yet RecruitingPrimary

Integrating U=U Into HIV Counseling in South Africa (INTUIT-2.0)

Scroll to load more

Research Network

Activity Timeline